Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 15 10:15AM ET
3.31
Dollar change
-0.40
Percentage change
-10.73
%
Index- P/E- EPS (ttm)-0.13 Insider Own23.45% Shs Outstand17.13M Perf Week31.95%
Market Cap56.71M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float13.11M Perf Month15.20%
Income-1.10M PEG- EPS next Q- Inst Own61.38% Short Float0.10% Perf Quarter-40.65%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.21 Perf Half Y-70.66%
Book/sh3.32 P/B1.00 EPS next Y- ROA-2.85% Short Interest0.01M Perf Year-68.00%
Cash/sh0.00 P/C1890.49 EPS next 5Y- ROE-4.11% 52W Range2.33 - 11.57 Perf YTD-69.61%
Dividend Est.- P/FCF- EPS past 5Y- ROI-4.88% 52W High-71.37% Beta0.03
Dividend TTM- Quick Ratio0.01 Sales past 5Y0.00% Gross Margin- 52W Low42.15% ATR (14)0.40
Dividend Ex-Date- Current Ratio0.01 EPS Y/Y TTM-197.12% Oper. Margin0.00% RSI (14)56.80 Volatility22.19% 11.60%
Employees3 Debt/Eq0.14 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q363.04% Payout- Rel Volume13.88 Prev Close3.71
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume63.62K Price3.31
SMA2019.54% SMA507.60% SMA200-60.39% Trades Volume140,980 Change-10.73%
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market of innovative ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in New York, NY.